상품명칭 |
에리스로마이신 포스페이트 |
별명 |
에리스로마이신 포스페이트; UNII-I8T8KU14X7; 에리스로마이신, 인산염; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(디메틸아미노)-3-하이드록시-6-메틸테트라하이드로-2H-피란-2-일]옥시}-14-에틸-7,12,13-트리하이드록시-4-{[(2R,4R,5S,6S)-5-히드록시-4-메톡시-4,6-디메틸테트라하이드로-2H-피란-2-일]옥시}-3,5,7,9,11,13-헥사메틸옥사사이클로테트레이드케인-2,10-디온 포스페이트(1:1)(비선호 명칭) |
영문 이름 |
erythromycin phosphate;Erythromycin phosphate; UNII-I8T8KU14X7; Erythromycin, phosphate; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione phosphate (1:1) (non-preferred name) |
분자식 |
C37H70NO17P |
분자량 |
831.922 |
InChI |
InChI=1/C37H67NO13.H3O4P/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26;1-5(2,3)4/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3;(H3,1,2,3,4)/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-;/m1./s1 |
cas번호 |
4501-00-2 |
EC번호 |
224-812-1 |
분자 구조 |
|
비등점 |
818.4°C at 760 mmHg |
인화점 |
448.8°C |
증기압 |
4.94E-31mmHg at 25°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|